Showing results (71-80 of 284) with videos related to
Sort By:
Pageof 29
STAR Protocols|January 3, 2023
Assessing human iPSC-derived microglia identity and function by immunostaining, phagocytosis, calcium activity, and inflammation assayVerena Hübschmann, Medina Korkut-Demirbaş, Sandra SiegertMini Reviews in Medicinal Chemistry|May 25, 2006
Novel anti-viral therapy: drugs that block HIV entry at different target sitesSandra Siegert, Peter Schnierle, Barbara S SchnierlePhysiological Reviews|April 30, 2011
Epigenetic regulation of gene expression in physiological and pathological brain processesJohannes Gräff, Dohoon Kim, Matthew M Dobbin, et al.Neurobiology of Learning and Memory|July 16, 2013
Forebrain-specific deletion of Cdk5 in pyramidal neurons results in mania-like behavior and cognitive impairmentSusan C Su, Andrii Rudenko, Sukhee Cho, et al.FEBS Letters|July 19, 2002
A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brainsHuang Chun Tseng, Ying Zhou, Yong Shen, et al.Nature|May 1, 2007
Recovery of learning and memory is associated with chromatin remodellingAndre Fischer, Farahnaz Sananbenesi, Xinyu Wang, et al.Neuroscience Letters|June 4, 2019
Targeting microglia with lentivirus and AAV: Recent advances and remaining challengesMargaret E Maes, Gloria Colombo, Rouven Schulz, et al.AIDS Research and Therapy|September 15, 2005
Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectorsSandra Siegert, Sonja Thaler, Ralf Wagner, et al.The Journal of Biological Chemistry|August 21, 2010
Control of activating transcription factor 4 (ATF4) persistence by multisite phosphorylation impacts cell cycle progression and neurogenesisChristopher L Frank, Xuecai Ge, Zhigang Xie, et al.The Journal of Biological Chemistry|November 29, 2001
GC box-binding transcription factors control the neuronal specific transcription of the cyclin-dependent kinase 5 regulator p35Sarah Ross, Anri Tienhaara, Ming-Sum Lee, et al.Pageof 29